Publications

2018

97.
Gautam Srivastava; Adi Moseri; Naama Kessler; Boris Arshava; Fred Naider; Jacob Anglister (2018). Defining specific residue-to-residue interactions between the gp120 bridging sheet and the N-terminal segment of CCR5: applications of transferred NOE NMR.  FEBS Journal. 285:(22)4296-4310.  Abstract
96.
Meital Abayev; Joao P. G. L. M. Rodrigues; Gautam Srivastava; Boris Arshava; Lukasz Jaremko; Mariusz Jaremko; Fred Naider; Michael Levitt; Jacob Anglister (2018). The solution structure of monomeric CCL5 in complex with a doubly sulfated N-terminal segment of CCR5.  FEBS Journal. 285:(11)1988-2003.  Abstract
95.
Fred Naider; Jacob Anglister (2018). The Synthesis of Sulfated CCR5 Peptide Surrogates and their Use to Study Receptor-Ligand Interactions.  Protein and Peptide Letters. 25:(12)1124-1136.  Abstract

2017

94.
Adi Moseri; Gautam Srivastava; Naama Kessler; B. Arshava; Fred Naider; Jacob Anglister (2017). Detection of pair-wise intermolecular interactions in large protein complexes using NMR tr-NOE and specific methyl labeling of HIV-1 gp120 in complex with a CCR5 peptide.  FEBS Journal. 284:196-196.  Abstract
93.
Meital Abayev; Gautam Srivastava; Boris Arshava; Fred Naider; Jacob Anglister (2017). Detection of intermolecular transferred-NOE interactions in small and medium size protein complexes: RANTES complexed with a CCR5 N-terminal peptide.  FEBS Journal. 284:(4)586-601.  Abstract
92.
Adi Moseri; Eshu Sinha; Henni Zommer; Boris Arshava; Fred Naider; Jacob Anglister (2017). Immunofocusing using conformationally constrained V3 peptide immunogens improves HIV-1 neutralization.  Vaccine. 35:(2)222-230.  Abstract

2016

91.
Gautam Srivastava; Adi Moseri; Naama Kessler; Sabine R. Akabayov; Boris Arshava; Fred Naider; Jacob Anglister (2016). Detection of intermolecular transferred NOEs in large protein complexes using asymmetric deuteration: HIV-1 gp120 in complex with a CCR5 peptide.  FEBS Journal. 283:(22)4084-4096.  Abstract
90.
Jacob Anglister; Gautam Srivastava; Fred Naider (2016). Detection of intermolecular NOE interactions in large protein complexes.  Progress in Nuclear Magnetic Resonance Spectroscopy. 97:40-56.  Abstract

2015

89.
Adi Moseri; Zohar Biron; Boris Arshava; Tali Scherf; Fred Naider; Jacob Anglister (2015). The C4 region as a target for HIV entry inhibitors - NMR mapping of the interacting segments of T20 and gp120.  The FEBS journal. 282:(24)4643-57.  Abstract
88.
Meital Abayev; Adi Moseri; Oren Tchaicheeyan; Naama Kessler; Boris Arshava; Fred Naider; Tali Scherf; Jacob Anglister (2015). An extended CCR5 ECL2 peptide forms a helix that binds HIV-1 gp120 through non-specific hydrophobic interactions.  FEBS Journal. 282:(10)1906-1921.  Abstract

2014

87.
Adi Moseri; Einat Schnur; Eran Noah et al. (2014). NMR observation of HIV-1 gp120 conformational flexibility resulting from V3 truncation.  FEBS Journal. 281:(13)3019-3031.  Abstract [All authors]

2013

86.
Adi Moseri; S. Tantry; B. Arshava; Fred Naider; Jacob Anglister (2013). Sequential Immunization Approach for the V3 Epitope Using Constrained Peptides.  AIDS Research and Human Retroviruses. 29:(11)A144-A144.  Abstract
85.
Einat Schnur; Naama Kessler; Yuri Zherdev et al. (2013). NMR mapping of RANTES surfaces interacting with CCR5 using linked extracellular domains.  FEBS Journal. 280:(9)2068-2084.  Abstract [All authors]
84.
Adi Moseri; Subramanyam Tantry; Fa-Xiang Ding; Fred Naider; Jacob Anglister (2013). Short Communication Synergism Between a CD4-Mimic Peptide and Antibodies Elicited by a Constrained V3 Peptide.  AIDS Research and Human Retroviruses. 29:(4)718-724.  Abstract

2011

83.
Adi Moseri; Yael Sagi; B. Arshava; Fred Naider; Jacob Anglister (2011). Optimization of the V3 Directed Antibody Response: Strategies to Expose the Epitope.  AIDS Research and Human Retroviruses. 27:(10)A44-A44.  Abstract
82.
Ilona Nudelman; Sabine R. Akabayov; Tali Scherf; Jacob Anglister (2011). Observation of Intermolecular Interactions in Large Protein Complexes by 2D-Double Difference Nuclear Overhauser Enhancement Spectroscopy: Application to the 44 kDa Interferon-Receptor Complex.  Journal of the American Chemical Society. 133:(37)14755-14764.  Abstract
81.
Einat Schnur; Eran Noah; Inbal Ayzenshtat et al. (2011). The Conformation and Orientation of a 27-Residue CCR5 Peptide in a Ternary Complex with HIV-1 gp120 and a CD4-Mimic Peptide.  Journal of Molecular Biology. 410:(5)778-797.  Abstract [All authors]

2010

80.
Ilona Nudelman; Sabine R. Akabayov; Einat Schnur; Zohar Biron; Rina Levy; Yingqi Xu; Daiwen Yang; Jacob Anglister (2010). Intermolecular Interactions in a 44 kDa Interferon-Receptor Complex Detected by Asymmetric Reverse-Protonation and Two-Dimensional NOESY.  Biochemistry. 49:(25)5117-5133.  Abstract
79.
Ilona Nudelman; S. R. Akabayov; Einat Schnur; Z. Biron; Ran Levy; Y. Xu; D. Yang; Jacob Anglister (2010). NMR structural studies of the human interferon-alpha 2 complex with human type I Interferon receptor.  FEBS Journal. 277:197-197.  Abstract
78.
Einat Schnur; Tali Scherf; Fred Naider; Jacob Anglister (2010). The HIV-1 gp120 interaction with Nt-CCR5-New insights from NMR.  FEBS Journal. 277:240-241.  Abstract
77.
Adi Moseri; Subramanyam Tantry; Yael Sagi; Boris Arshava; Fred Naider; Jacob Anglister (2010). An optimally constrained V3 peptide is a better immunogen than its linear homolog or HIV-1 gp120.  Virology. 401:(2)293-304.  Abstract
76.
Osnat Rosen; Adi Moseri; Jacob Anglister (2010). HIV V3 structures as novel HIV immunogens.  FEBS Journal. 277:92-92.  Abstract
75.
Sabine Ruth Akabayov; Zohar Biron; Peter Lamken; Jacob Piehler; Jacob Anglister (2010). NMR Mapping of the IFNAR1-EC Binding Site on IFN alpha 2 Reveals Allosteric Changes in the IFNAR2-EC Binding Site.  Biochemistry. 49:(4)687-695.  Abstract

2009

74.
Brenda Mester; Revital Manor; Amit Mor; Boris Arshava; Osnat Rosen; Fa-Xiang Ding; Fred Naider; Jacob Anglister (2009). HIV-1 Peptide Vaccine Candidates: Selecting Constrained V3 Peptides with Highest Affinity to Antibody 447-52D.  Biochemistry. 48:(33)7867-7877.  Abstract
73.
Fred Naider; Jacob Anglister (2009). Peptides in the treatment of AIDS.  Current Opinion in Structural Biology. 19:(4)473-482.  Abstract
72.
Osnat Rosen; Adi Moseri; Jacob Anglister (2009). HIV V3 region structures as novel HIV immunogens.  FEBS Journal. 276:163-163.  Abstract
71.
Arnit Mor; Eugenia Segal; Brenda Mester et al. (2009). Mimicking the Structure of the V3 Epitope Bound to HIV-1 Neutralizing Antibodies.  Biochemistry. 48:(15)3288-3303.  Abstract [All authors]
70.
S. Tantry; Adi Moseri; B. Arshava; Fred Naider; Jacob Anglister (2009). SYNTHESIS AND BIOLOGICAL EVALUATION OF CONSTRAINED V3-PEPTIDE ANTI HIV-1 IMMUNOGENS CONJUGATED TO A T-CELL EPITOPE.  Biopolymers. 92:(4)326-326.  Abstract
69.
Adi Moseri; Fred Naider; Jacob Anglister (2009). The V3 region of HIV-1: from NMR to vaccine design.  Retrovirology. 6.  Abstract
68.
Osnat Rosen; Jacob Anglister (2009). Epitope Mapping of Antibody-Antigen Complexes by Nuclear Magnetic Resonance Spectroscopy.  Epitope Mapping Protocols, Second Edition. 37-57.  Abstract

2008

67.
Adi Moseri; Jacob Anglister (2008). HIV-1 V3 Peptides Constrained to their Native Conformation as Vaccine Candidates.  AIDS Research and Human Retroviruses. 24:95-95.  Abstract
66.
Osnat Rosen; Adi Moseri; Jacob Anglister (2008). HIV V3 Region Structures as Novel HIV Immunogens.  AIDS Research and Human Retroviruses. 24:93-93.  Abstract
65.
Eran Noah; Zohar Biron; Fred Naider; Boris Arshava; Jacob Anglister (2008). The membrane proximal external region of the HIV-1 envelope glycoprotein gp41 contributes to the stabilization of the six-helix bundle formed with a matching N ' peptide.  Biochemistry. 47:(26)6782-6792.  Abstract
64.
Osnat Rosen; Avraham O. Samson; Jacob Anglister (2008). Correlated mutations at gp120 positions 322 and 440: Implications for gp120 structure.  Proteins-Structure Function And Bioinformatics. 71:(3)1066-1070.  Abstract
63.
Einat Schnur; Michael Turkov; Roy Kahn; Dalia Gordon; Michael Gurevitz; Jacob Anglister (2008). NMR analysis of interaction of Lqh alpha IT scorpion toxin with a peptide corresponding to the D4/S3-S4 loop of insect para voltage-gated sodium channel.  Biochemistry. 47:(3)911-921.  Abstract

2007

62.
Jacob Anglister; Osnat Rosen; Michal Sharon; Vitali Tugarinov; Naama Kessler; Rina Levy (2007). NMR structures of the HIV-1 v3 region suggest a mechanism for the virus phenotype conversion.  Journal of biomolecular structure & dynamics. 24:(6)670-670.  Abstract
61.
Jacob Anglister; E. Goldberg; Dalia Gordon; M. Gurevitz (2007). NMR mapping of scorpion-toxin binding-site for a peptide derived from the D4/S3-S4 loop of a voltage gated sodium channel.  Biopolymers. 88:(4)630-630.  Abstract

2006

60.
Sabine R. Quadt-Akabayov; Jordan H. Chill; Rina Levy; Naama Kessler; Jacob Anglister (2006). Determination of the human type I interferon receptor binding site on human interferon-alpha 2 by cross saturation and an NMR-based model of the complex.  Protein Science. 15:(11)2656-2668.  Abstract
59.
Osnat Rosen; Michal Sharon; Sabine R. Quadt-Akabayov; Jacob Anglister (2006). Molecular switch for alternative conformations of the HIV-1V3 region: Implications for phenotype conversion.  Proceedings of the National Academy of Sciences of the United States of America. 103:(38)13950-13955.  Abstract
58.
Osnat Rosen; AO Samson; Michal Sharon; S Zolla-Pazner; Jacob Anglister (2006). HIV-1 coreceptor selectivity: Structural analogy between HIV-1V3 regions and chemokine beta-hairpins is not the explanation - Response to matters arising.  Structure. 14:(4)649-651.
57.
J Garcia; P Dumy; Osnat Rosen; Jacob Anglister (2006). Stabilization of the biologically active conformation of the principal neutralizing determinant of HIV-1(III)B containing a cis-proline surrogate: H-1 NMR and molecular modeling study.  Biochemistry. 45:(13)4284-4294.  Abstract

2005

56.
Z Biron; S Khare; SR Quadt; Y Hayek; Fred Naider; Jacob Anglister (2005). The 2F5 epitope is helical in the HIV-1 entry inhibitor T-20.  Biochemistry. 44:(41)13602-13611.  Abstract
55.
Michal Sharon; Osnat Rosen; Jacob Anglister (2005). NMR studies of V3 peptide complexes with antibodies suggest a mechanism for HIV-1 co-receptor selectivity.  Current Opinion In Drug Discovery & Development. 8:(5)601-612.  Abstract
54.
AO Samson; JH Chill; Jacob Anglister (2005). Two-dimensional measurement of proton T-1p relaxation in unlabeled proteins: Mobility changes in alpha-bungarotoxin upon binding of an acetylcholine receptor peptide.  Biochemistry. 44:(32)10926-10934.  Abstract
53.
Osnat Rosen; J Chill; Michal Sharon; Naama Kessler; B Mester; S Zolla-Pazner; Jacob Anglister (2005). Induced fit in HIV-neutralizing antibody complexes: Evidence for alternative conformations of the gp120 V3 loop and the molecular basis for broad neutralization.  Biochemistry. 44:(19)7250-7258.  Abstract
52.
H Sargsyan; B Arshava; P Cano; T Inui; Jacob Anglister; Fred Naider (2005). An efficient and facile synthesis of a sulfated tyrosine-containing peptide: Synthesis of an analog of the N-terminal peptide of CCR5.  Biopolymers. 80:(4)535-535.  Abstract
51.
P Cano; T Inui; B Arshava; I Ayzenshtat; Jacob Anglister; Fred Naider (2005). Synthesis and NMR analysis of CCR5 and CXCR4 peptides containing tyrosine sulfate.  Biopolymers. 80:(4)526-526.  Abstract

2004

50.
JH Chill; SR Quadt; Jacob Anglister (2004). NMR backbone dynamics of the human type I interferon binding subunit, a representative cytokine receptor.  Biochemistry. 43:(31)10127-10137.  Abstract

2003

49.
JH Chill; SR Quadt; Ran Levy; Gideon Schreiber; Jacob Anglister (2003). The human type I interferon receptor: NMR structure reveals the molecular basis of ligand binding.  Structure. 11:(7)791-802.  Abstract
48.
Naama Kessler; A Zvi; M Ji; Michal Sharon; Osnat Rosen; Ran Levy; M Gorny; S Zolla-Pazner; Jacob Anglister (2003). Expression, purification, and isotope labeling of the Fv of the human HIV-1 neutralizing antibody 447-52D for NMR studies.  Protein Expression and Purification. 29:(2)291-303.  Abstract
47.
Michal Sharon; Naama Kessler; Ran Levy; S Zolla-Pazner; M Gorlach; Jacob Anglister (2003). Alternative conformations of HIV-1V3 loops mimic beta hairpins in chemokines, suggesting a mechanism for coreceptor selectivity.  Structure. 11:(2)225-236.  Abstract

2002

46.
Z Biron; S Khare; AO Samson; Y Hayek; Fred Naider; Jacob Anglister (2002). A monomeric 3(10)-helix is formed in water by a 13-residue peptide representing the neutralizing determinant of HIV-1 on gp41.  Biochemistry. 41:(42)12687-12696.  Abstract
45.
AO Samson; Tali Scherf; Miriam Eisenstein; JH Chill; Jacob Anglister (2002). The mechanism for acetylcholine receptor inhibition by alpha-neurotoxins and species-specific resistance to alpha-bungarotoxin revealed by NMR.  Neuron. 35:(2)319-332.  Abstract
44.
Michal Sharon; M Gorlach; Ran Levy; Y Hayek; Jacob Anglister (2002). Expression, purification, and isotope labeling of a gp120 V3 peptide and production of a Fab from a HIV-1 neutralizing antibody for NMR studies.  Protein Expression and Purification. 24:(3)374-383.  Abstract
43.
RL Nivasch; J Chill; Jacob Anglister (2002). NMR-based homology model of the interferon alpha receptor.  ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. 223:U302-U303.  Abstract
42.
Y Yao; JM Wang; N Viroonchatapan; A Samson; J Chill; E Rothe; Jacob Anglister; ZZ Wang (2002). Yeast expression and NMR analysis of the extracellular domain of muscle nicotinic acetylcholine receptor alpha subunit.  Journal of Biological Chemistry. 277:(15)12613-12621.  Abstract
41.
JH Chill; R Nivasch; Ran Levy; Shira Albeck; Gideon Schreiber; Jacob Anglister (2002). The human interferon receptor: NMR-based modeling, mapping of the IFN-alpha 2 binding site, and observed ligand-induced tightening.  Biochemistry. 41:(11)3575-3585.  Abstract

2001

40.
AO Samson; JH Chill; E Rodriguez; Tali Scherf; Jacob Anglister (2001). NMR mapping and secondary structure determination of the major acetylcholine receptor alpha-subunit determinant interacting with alpha-bungarotoxin.  Biochemistry. 40:(18)5464-5473.  Abstract

2000

39.
O Froy; N Zilberberg; N Chejanovsky; Jacob Anglister; E Loret; B Shaanan; Dalia Gordon; M Gurevitz (2000). Scorpion neurotoxins: structure/function relationships and application in agriculture.  Pest Management Science. 56:(5)472-474.  Abstract
38.
JJ Balbach; J Yang; DP Weliky; PJ Steinbach; V Tugarinov; Jacob Anglister; R Tycko (2000). Probing hydrogen bonds in the antibody-bound HIV-1 gp120 V3 loop by solid state NMR REDOR measurements.  Journal of Biomolecular NMR. 16:(4)313-327.  Abstract
37.
V Tugarinov; A Zvi; Ran Levy; Y Hayek; S Matsushita; Jacob Anglister (2000). NMR structure of an anti-gp120 antibody complex with a V3 peptide reveals a surface important for co-receptor binding.  Structure with Folding & design. 8:(4)385-395.  Abstract
36.
A Zvi; V Tugarinov; GA Faiman; Amnon Horovitz; Jacob Anglister (2000). A model of a gp120 V3 peptide in complex with an HIV-neutralizing antibody based on NMR and mutant cycle-derived constraints.  FEBS Journal. 267:(3)767-779.  Abstract
35.
V Tugarinov; Jacob Anglister (2000). Solution structure of an antibody-bound HIV-1(IIIB)V3 peptide: A cis proline turn linking two beta-hairpin strands.  Journal of biomolecular structure & dynamics. 57-63.  Abstract

1999

34.
Michal Sharon; Z Oren; Yechiel Shai; Jacob Anglister (1999). 2D-NMR and ATR-FTIR study of the structure of a cell-selective diastereomer of melittin and its orientation in phospholipids.  Biochemistry. 38:(46)15305-15316.  Abstract
33.
V Tugarinov; A Zvi; Ran Levy; Jacob Anglister (1999). A cis proline turn linking two beta-hairpin strands in the solution structure of an antibody-bound HIV-1(IIIB) V3 peptide.  Nature Structural Biology. 6:(4)331-335.  Abstract
32.
V Tugarinov; Ran Levy; A Dahan-Schokoroy; Jacob Anglister (1999). Letter to the Editor: Backbone and C-beta assignments of the anti-gp120 antibody Fv fragment complexed with an antigenic peptide.  Journal of Biomolecular NMR. 13:(2)193-194.
31.
DP Weliky; AE Bennett; A Zvi; Jacob Anglister; PJ Steinbach; R Tycko (1999). Solid-state NMR evidence for an antibody-dependent conformation of the V3 loop of HIV-1 gp120.  Nature Structural Biology. 6:(2)141-145.  Abstract
30.
A Zvi; Jacob Anglister (1999). Application of NMR to conformational studies of an HIV peptide bound to a neutralizing antibody.  Nmr In Supramolecular Chemistry. 526:117-132.  Abstract

1998

29.
A Zvi; Jacob Anglister (1998). The principal neutralizing determinant of HIV-1(IIIB): Conformation Of the peptide bound to a neutralizing antibody studied by 2D-NMR.  International Journal of Peptide Research and Therapeutics. 5:(6-May)357-364.  Abstract

1997

28.
A Zvi; DJ Feigelson; Y Hayek; Jacob Anglister (1997). Conformation of the principal neutralizing determinant of human immunodeficiency virus type 1 in complex with an anti-gp120 virus neutralizing antibody studied by two-dimensional nuclear magnetic resonance difference spectroscopy.  Biochemistry. 36:(28)8619-8627.  Abstract
27.
Tali Scherf; M Balass; Shai Fuchs; E KatchalskiKatzir; Jacob Anglister (1997). Three-dimensional solution structure of the complex of alpha-bungarotoxin with a library-derived peptide.  Proceedings of the National Academy of Sciences of the United States of America. 94:(12)6059-6064.  Abstract
26.
V Tugarinov; I Kustanovich; N Zilberberg; M Gurevitz; Jacob Anglister (1997). Solution structures of a highly insecticidal recombinant scorpion alpha-toxin and a mutant with increased activity.  Biochemistry. 36:(9)2414-2424.  Abstract

1996

25.
GA Faiman; Ran Levy; Jacob Anglister; Amnon Horovitz (1996). Contribution of arginine residues in the RP135 peptide derived from the V3 loop of gp120 to its interaction with the Fv fragment of the 0.5 beta HIV-1 neutralizing antibody.  Journal of Biological Chemistry. 271:(23)13829-13833.  Abstract

1995

24.
Jacob Anglister; H REN; CB KLEE; A BAX (1995). NMR IDENTIFICATION OF CALCINEURIN-B RESIDUES AFFECTED BY BINDING OF A CALCINEURIN-A PEPTIDE.  FEBS Letters. 375:(2-Jan)108-112.  Abstract
23.
A ZVI; I KUSTANOVICH; Y HAYEK; S MATSUSHITA; Jacob Anglister (1995). THE PRINCIPAL NEUTRALIZING DETERMINANT OF HIV-1 LOCATED IN V3 OF GP120 FORMS A 12-RESIDUE LOOP BY INTERNAL HYDROPHOBIC INTERACTIONS.  FEBS Letters. 368:(2)267-270.  Abstract
22.
Menachem Shoham; Tali Scherf; Jacob Anglister; M LEVITT; EA MERRITT; WGJ HOL (1995). STRUCTURAL DIVERSITY IN A CONSERVED CHOLERA-TOXIN EPITOPE INVOLVED IN GANGLIOSIDE BINDING.  Protein Science. 4:(5)841-848.  Abstract
21.
A ZVI; I KUSTANOVICH; D FEIGELSON; Ran Levy; Miriam Eisenstein; S MATSUSHITA; P RICHALETSECORDEL; MHV REGENMORTEL; Jacob Anglister (1995). NMR MAPPING OF THE ANTIGENIC DETERMINANT RECOGNIZED BY AN ANTI-GP120, HUMAN-IMMUNODEFICIENCY-VIRUS NEUTRALIZING ANTIBODY.  FEBS Journal. 229:(1)178-187.  Abstract
20.
Tali Scherf; R HILLER; Jacob Anglister (1995). NMR OBSERVATION OF INTERACTIONS IN THE COMBINING SITE REGION OF AN ANTIBODY USING A SPIN-LABELED PEPTIDE ANTIGEN AND NOESY DIFFERENCE SPECTROSCOPY.  FASEB Journal. 9:(1)120-126.  Abstract
19.
Jacob Anglister; Tali Scherf; B ZILBER; Ran Levy (1995). 2-DIMENSIONAL NMR-STUDIES OF THE INTERACTIONS BETWEEN A PEPTIDE OF CHOLERA-TOXIN AND MONOCLONAL-ANTIBODIES.  Biopolymers. 37:(6)383-389.  Abstract

1994

18.
Jacob Anglister; S GRZESIEK; AC WANG; H REN; CB KLEE; A BAX (1994). H-1, C-13, N-15 NUCLEAR-MAGNETIC-RESONANCE BACKBONE ASSIGNMENTS AND SECONDARY STRUCTURE OF HUMAN CALCINEURIN-B.  Biochemistry. 33:(12)3540-3547.  Abstract

1993

17.
Jacob Anglister; Tali Scherf; B ZILBER; Ran Levy; A ZVI; R HILLER; D FEIGELSON (1993). 2-DIMENSIONAL NMR INVESTIGATIONS OF THE INTERACTIONS OF ANTIBODIES WITH PEPTIDE ANTIGENS.  FASEB Journal. 7:(12)1154-1162.  Abstract
16.
Tali Scherf; Jacob Anglister (1993). A T(1-RHO)-FILTERED 2-DIMENSIONAL TRANSFERRED NOE SPECTRUM FOR STUDYING ANTIBODY INTERACTIONS WITH PEPTIDE ANTIGENS.  Biophysical Journal. 64:(3)754-761.  Abstract

1992

15.
A ZVI; R HILLER; Jacob Anglister (1992). SOLUTION CONFORMATION OF A PEPTIDE CORRESPONDING TO THE PRINCIPAL NEUTRALIZING DETERMINANT OF HIV-1(IIIB) - A 2-DIMENSIONAL NMR-STUDY.  Biochemistry. 31:(30)6972-6979.  Abstract
14.
Tali Scherf; R HILLER; Fred Naider; M LEVITT; Jacob Anglister (1992). INDUCED PEPTIDE CONFORMATIONS IN DIFFERENT ANTIBODY COMPLEXES - MOLECULAR MODELING OF THE 3-DIMENSIONAL STRUCTURE OF PEPTIDE ANTIBODY COMPLEXES USING NMR-DERIVED DISTANCE RESTRAINTS.  Biochemistry. 31:(30)6884-6897.  Abstract

1991

13.
Jacob Anglister; Fred Naider (1991). NUCLEAR-MAGNETIC-RESONANCE FOR STUDYING PEPTIDE ANTIBODY COMPLEXES BY TRANSFERRED NUCLEAR OVERHAUSER EFFECT DIFFERENCE SPECTROSCOPY.  Methods in Enzymology. 203:228-241.

1990

12.
B ZILBER; Tali Scherf; M LEVITT; Jacob Anglister (1990). NMR-DERIVED MODEL FOR A PEPTIDE-ANTIBODY COMPLEX.  Biochemistry. 29:(43)10032-10041.
11.
Jacob Anglister (1990). USE OF DEUTERIUM LABELING IN NMR-STUDIES OF ANTIBODY COMBINING SITE STRUCTURE.  Quarterly Reviews of Biophysics. 23:(2)175-203.
10.
Jacob Anglister; B ZILBER (1990). ANTIBODIES AGAINST A PEPTIDE OF CHOLERA-TOXIN DIFFERING IN CROSS-REACTIVITY WITH THE TOXIN DIFFER IN THEIR SPECIFIC INTERACTIONS WITH THE PEPTIDE AS OBSERVED BY H-1-NMR SPECTROSCOPY.  Biochemistry. 29:(4)921-928.

1989

9.
Ran Levy; O ASSULIN; Tali Scherf; M LEVITT; Jacob Anglister (1989). PROBING ANTIBODY DIVERSITY BY 2D NMR - COMPARISON OF AMINO-ACID SEQUENCES, PREDICTED STRUCTURES, AND OBSERVED ANTIBODY ANTIGEN INTERACTIONS IN COMPLEXES OF 2 ANTIPEPTIDE ANTIBODIES.  Biochemistry. 28:(18)7168-7175.
8.
Jacob Anglister; Ran Levy; Tali Scherf (1989). INTERACTIONS OF ANTIBODY AROMATIC RESIDUES WITH A PEPTIDE OF CHOLERA-TOXIN OBSERVED BY TWO-DIMENSIONAL TRANSFERRED NUCLEAR OVERHAUSER EFFECT DIFFERENCE SPECTROSCOPY.  Biochemistry. 28:(8)3360-3365.

1988

7.
T FREY; Jacob Anglister; HM MCCONNELL (1988). LINE-SHAPE ANALYSIS OF NMR DIFFERENCE SPECTRA OF AN ANTI-SPIN-LABEL ANTIBODY.  Biochemistry. 27:(14)5161-5165.
6.
Jacob Anglister; C JACOB; O ASSULIN; G AST; R PINKER; Ruth Arnon (1988). NMR-STUDY OF THE COMPLEXES BETWEEN A SYNTHETIC PEPTIDE DERIVED FROM THE B-SUBUNIT OF CHOLERA-TOXIN AND 3 MONOCLONAL-ANTIBODIES AGAINST IT.  Biochemistry. 27:(2)717-724.

1987

5.
Jacob Anglister; MW BOND; T FREY; D LEAHY; M LEVITT; HM MCCONNELL; GS RULE; J TOMASELLO; M WHITTAKER (1987). CONTRIBUTION OF TRYPTOPHAN RESIDUES TO THE COMBINING SITE OF A MONOCLONAL ANTI DINITROPHENYL SPIN-LABEL ANTIBODY.  Biochemistry. 26:(19)6058-6064.

1983

4.
Jacob Anglister; IZ STEINBERG (1983). RESONANCE RAYLEIGH LIGHT-SCATTERING OF SOME PORPHYRINS IN SOLUTION - INTENSITIES AND DEPOLARIZATION RATIOS.  Chemical Physics. 75:(3)443-452.
3.
Jacob Anglister; IZ STEINBERG (1983). RESONANCE RAYLEIGH-SCATTERING OF CYANINE DYES IN SOLUTION.  Journal of Chemical Physics. 78:(9)5358-5368.

1981

2.
Jacob Anglister; IZ STEINBERG (1981). MEASUREMENT OF THE DEPOLARIZATION RATIO OF RAYLEIGH-SCATTERING AT ABSORPTION-BANDS.  Journal of Chemical Physics. 74:(2)786-791.

1979

1.
Jacob Anglister; IZ STEINBERG (1979). DEPOLARIZED RAYLEIGH LIGHT-SCATTERING IN ABSORPTION-BANDS MEASURED IN LYCOPENE SOLUTION.  Chemical Physics Letters. 65:(1)50-54.